tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
CG Oncology price target raised to $79 from $56 at Morgan Stanley
PremiumThe FlyCG Oncology price target raised to $79 from $56 at Morgan Stanley
25d ago
Citizens JMP healthcare analysts hold an analyst/industry conference call
Premium
The Fly
Citizens JMP healthcare analysts hold an analyst/industry conference call
26d ago
Premium
Ratings
Buy Rating for CG Oncology: Creto’s Market Potential and Strategic Pricing Flexibility
27d ago
PremiumRatingsBuy Rating for CG Oncology, Inc.: Promising Data on Creto’s Efficacy and Safety in NMIBC Treatment
1M ago
Premium
Ratings
CG Oncology’s Promising Clinical Results and Strategic Positioning Drive Buy Rating
1M ago
Premium
Ratings
Promising Phase 3 Results for CG Oncology’s Cretostimogene Highlight Competitive Edge in Bladder Cancer Treatment
1M ago
CG Oncology initiated with an Overweight at Piper Sandler
PremiumThe FlyCG Oncology initiated with an Overweight at Piper Sandler
2M ago
CG Oncology initiated with an Overweight at Piper Sandler
Premium
The Fly
CG Oncology initiated with an Overweight at Piper Sandler
2M ago
Premium
Ratings
CG Oncology’s Strategic Advancements and Promising Data Reinforce Buy Rating
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100